- Home
- PLRZ vs EVOK Comparison
PLRZ vs EVOK Comparison
Compare PLRZ & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- EVOK
- Stock Information
- Founded
- PLRZ 2005
- EVOK 2007
- Country
- PLRZ Israel
- EVOK United States
- Employees
- PLRZ N/A
- EVOK N/A
- Industry
- PLRZ
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- PLRZ
- EVOK Health Care
- Exchange
- PLRZ NYSE
- EVOK Nasdaq
- Market Cap
- PLRZ 3.7M
- EVOK 4.2M
- IPO Year
- PLRZ 2024
- EVOK 2013
- Fundamental
- Price
- PLRZ $0.71
- EVOK $6.09
- Analyst Decision
- PLRZ
- EVOK
- Analyst Count
- PLRZ 0
- EVOK 0
- Target Price
- PLRZ N/A
- EVOK N/A
- AVG Volume (30 Days)
- PLRZ 2.9M
- EVOK 7.2M
- Earning Date
- PLRZ 02-15-2025
- EVOK 08-12-2025
- Dividend Yield
- PLRZ N/A
- EVOK N/A
- EPS Growth
- PLRZ N/A
- EVOK N/A
- EPS
- PLRZ N/A
- EVOK N/A
- Revenue
- PLRZ N/A
- EVOK $11,594,083.00
- Revenue This Year
- PLRZ N/A
- EVOK $57.82
- Revenue Next Year
- PLRZ N/A
- EVOK $59.12
- P/E Ratio
- PLRZ N/A
- EVOK N/A
- Revenue Growth
- PLRZ N/A
- EVOK 89.89
- 52 Week Low
- PLRZ $0.55
- EVOK $1.94
- 52 Week High
- PLRZ $1,200.00
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- EVOK 74.84
- Support Level
- PLRZ N/A
- EVOK $2.52
- Resistance Level
- PLRZ N/A
- EVOK $9.88
- Average True Range (ATR)
- PLRZ 0.00
- EVOK 0.49
- MACD
- PLRZ 0.00
- EVOK 0.39
- Stochastic Oscillator
- PLRZ 0.00
- EVOK 49.19
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.